Barcelona, Spain – 23 Aug 2022: Short-term use of non-steroidal anti-inflammatory drugs (NSAIDs) is associated with a first-time hospitalisation for heart failure in patients with type 2 diabetes, ...
January 12, 2011 — New data showing nonsteroidal anti-inflammatory drugs (NSAIDs) have cardiovascular risks are putting the well-known pain relievers back in the headlines. Investigators evaluating ...
Correspondence to Dr Stuart J Warden, Department of Physical Therapy, School of Health and Rehabilitation Sciences, Indiana University, 1140 W Michigan St, CF-326, Indianapolis, IN 46202, USA; ...
(Philadelphia, PA) - It is well known that aspirin, a non-selective, non-steroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX), reduces the risk of heart attack and stroke.
To the Editor: The study by in 't Veld et al. (Nov. 22 issue) 1 on the prevention of Alzheimer's disease with nonsteroidal antiinflammatory drugs (NSAIDs) includes no mortality data. It is entirely ...
8 Center for Clinical Technology and Research of Joint Surgery, Hunan, China Correspondence to Dr Guanghua Lei, Department of Orthopaedics, Xiangya Hospital, Central South University, Changsha, Hunan, ...
The discovery last year that the painkillers Vioxx and Celebrex may increase the risk of heart problems wasn’t just a disappointment to people with chronic pain and the doctors who treat them. The ...
NEW DELHI: Research at Indian Institute of Technology (IIT), Madras promises a new line of treatment for mild to moderate Covid infection. Trials designed by researchers at IIT-M have shown efficacy ...
The FDA approved oral givinostat (Duvyzat) to treat Duchenne muscular dystrophy (DMD) in patients ages 6 years and older, the agency announced Thursday. Givinostat is a histone deacetylase (HDAC) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results